. 2021 Jul 6;12:20406207211027458. doi: 10.1177/20406207211027458
© The Author(s), 2021
This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Figure 1.
Combination mechanism of action of tafasitamab and lenalidomide. 41